Angharad Ames, MD
Psychiatry · Costa Mesa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 8 years
- Graduated 2018
Offices
1 location · Southern California Tms Center Inc · 6 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Ames’s office at (866) 322-7776 to ask if they take your plan before you enroll.
California Medical Board record
Licence A165388 · Current
Licensed to practise in California · since 2019 · expires 2027-09-30 · University of California, San Diego School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Psychiatry
Drugs they prescribed that Part D paid
$17,657
Pharmacies billed $17,657 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 220) in 2024. At or below the middle of the specialty; the typical psychiatry & neurology clinician is at 0%.
193 generic and 27 brand-name prescriptions · $17,657 in drug cost · 15 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Belsomra | 20 | $8,097 | $405 |
| Sertraline | 19 | $572 | $30 |
| Olanzapine | 24 | $294 | $12 |
| Divalproex | 24 | $276 | $11 |
| Gabapentin | 15 | $141 | $9 |
See all 8 drugs
| Belsomra | 20 | $8,097 | $405 |
| Sertraline | 19 | $572 | $30 |
| Olanzapine | 24 | $294 | $12 |
| Divalproex | 24 | $276 | $11 |
| Gabapentin | 15 | $141 | $9 |
| Quetiapine | 13 | $117 | $9 |
| Bupropion | 13 | $112 | $9 |
| Clonazepam | 16 | $86 | $5 |
Year by year
| 2024 | 220 | None | 0% (0) | 12% | $17,657 |
| 2023 | 144 | None | 0% (0) | 13% | $15,077 |
| 2022 | 40 | None | 0% (0) | None | $2,687 |
| 2021 | 89 | None | 0% (0) | None | $8,894 |
| 2020 | 41 | None | 0% (0) | None | $6,350 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Belsomra | 11 | $5,467 | $497 |
| Olanzapine | 24 | $588 | $25 |
| Divalproex | 24 | $460 | $19 |
| Bupropion Hcl Sr | 14 | $122 | $9 |
Money from drug and device companies
$54 in 2025
| 2025 | 2 | 2 | None | $54 |
| 2024 | 1 | 1 | None | $38 |
| 2023 | 1 | 2 | None | $37 |
| 2022 | 1 | 1 | None | $22 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alkermes | Aristada | $34 | 1 payment
|
| Janssen Pharmaceuticals | Spravato | $20 | 1 payment
|
See all 2 published payments
| Janssen Pharmaceuticals | Meals · 2025-09-22 | Spravato | $20 |
| Alkermes | Meals · 2025-05-29 | Aristada | $34 |
See earlier years (2024, 2023, 2022)
2024: $38
| Janssen Pharmaceuticals | Spravato | $38 | 1 payment
|
2023: $37
| Idorsia Pharmaceuticals US | Quviviq | $37 | 2 payments
|
2022: $22
| Sunovion Pharmaceuticals | Latuda | $22 | 1 payment
|
Professional record
- NPI
- 1467949727
- Licence
- CA A165388California A165388: Current · expires 2027-09-30
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 14350 Meridian Parkway, Box 2, Riverside, CA, 92508
- NPI first listed
- 2018-04-21
- NPI last updated
- 2020-02-08
- NPI record certified
- 2020-02-08
This is when the NPI record was last certified, not a medical board exam.